These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18208851)

  • 41. The National Center for Oncological Hadron Therapy: status of the project and future clinical use of the facility.
    Orecchia R; Fossati P; Rossi S
    Tumori; 2009; 95(2):169-76. PubMed ID: 19579862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct comparison of biologically optimized spread-out bragg peaks for protons and carbon ions.
    Wilkens JJ; Oelfke U
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):262-6. PubMed ID: 17935903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbon ion radiotherapy: impact of tumor differentiation on local control in experimental prostate carcinomas.
    Glowa C; Peschke P; Brons S; Neels OC; Kopka K; Debus J; Karger CP
    Radiat Oncol; 2017 Nov; 12(1):174. PubMed ID: 29121984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiotherapy systems using proton and carbon beams.
    Jongen Y
    Bull Mem Acad R Med Belg; 2008; 163(10-12):471-8; discussion 479-80. PubMed ID: 20120253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Basics of particle therapy: introduction to hadrons.
    Welsh JS
    Am J Clin Oncol; 2008 Oct; 31(5):493-5. PubMed ID: 18838888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of potential advantages of relevant ions for particle therapy: a model based study.
    Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
    Med Phys; 2015 Feb; 42(2):1037-47. PubMed ID: 25652516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Current use and prospects for hadron therapy in 2015].
    Feuvret L; Calugaru V; Ferrand R
    Cancer Radiother; 2015 Oct; 19(6-7):519-25. PubMed ID: 26337473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Particle radiation therapy using proton and heavier ion beams.
    Schulz-Ertner D; Tsujii H
    J Clin Oncol; 2007 Mar; 25(8):953-64. PubMed ID: 17350944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons.
    Ramaekers BL; Pijls-Johannesma M; Joore MA; van den Ende P; Langendijk JA; Lambin P; Kessels AG; Grutters JP
    Cancer Treat Rev; 2011 May; 37(3):185-201. PubMed ID: 20817407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Particle therapy in lung cancer: where do we stand?
    Pijls-Johannesma M; Grutters JP; Lambin P; Ruysscher DD
    Cancer Treat Rev; 2008 May; 34(3):259-67. PubMed ID: 18226466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological characteristics of carbon-ion therapy.
    Ando K; Kase Y
    Int J Radiat Biol; 2009 Sep; 85(9):715-28. PubMed ID: 19728191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conformal radiation therapy with hadron beams and the programs of the TERA Foundation.
    Amaldi U
    Rays; 1998; 23(3):486-507. PubMed ID: 9932467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medical Applications at CERN and the ENLIGHT Network.
    Dosanjh M; Cirilli M; Myers S; Navin S
    Front Oncol; 2016; 6():9. PubMed ID: 26835422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical experience with particle therapy in adults.
    Schulz-Ertner D
    Cancer J; 2009; 15(4):306-11. PubMed ID: 19672147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Monte Carlo study for the calculation of the average linear energy transfer (LET) distributions for a clinical proton beam line and a radiobiological carbon ion beam line.
    Romano F; Cirrone GA; Cuttone G; Rosa FD; Mazzaglia SE; Petrovic I; Fira AR; Varisano A
    Phys Med Biol; 2014 Jun; 59(12):2863-82. PubMed ID: 24828462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trials and tribulations in charged particle radiotherapy.
    Goitein M
    Radiother Oncol; 2010 Apr; 95(1):23-31. PubMed ID: 19581014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current status and new developments in ion therapy.
    Karger CP; Jäkel O
    Strahlenther Onkol; 2007 Jun; 183(6):295-300. PubMed ID: 17520182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical experience of carbon ion radiotherapy for malignant tumors].
    Ishikawa H; Tsuji H; Tsujii H
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):444-9. PubMed ID: 16612151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. History of hadron therapy accelerators.
    Degiovanni A; Amaldi U
    Phys Med; 2015 Jun; 31(4):322-32. PubMed ID: 25812487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Profile of European proton and carbon ion therapy centers assessed by the EORTC facility questionnaire.
    Weber DC; Abrunhosa-Branquinho A; Bolsi A; Kacperek A; Dendale R; Geismar D; Bachtiary B; Hall A; Heufelder J; Herfarth K; Debus J; Amichetti M; Krause M; Orecchia R; Vondracek V; Thariat J; Kajdrowicz T; Nilsson K; Grau C
    Radiother Oncol; 2017 Aug; 124(2):185-189. PubMed ID: 28764925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.